By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



P. Fluvial, 24
Parets del Vall├Ęs
Barcelona    08150  Spain
Phone: 9-357-10400 Fax: 9-357-10294



Company News
Plasma Medication Manufacturer Grifols Opens State-Of-The-Art Facility In North Carolina, 200 New Jobs On The Horizon 6/17/2014 11:13:20 AM
Grifols Completes Patient Enrollment In Its Phase2/3 Psoriasis Trial; Final Results Are Expected In Q1 2015 6/17/2014 10:50:26 AM
TiGenix: Appoints Gri-Cel CEO Dirk Buscher And COO Jose Terencio To Board Of Directors Following Strategic Investment By Grifols 12/5/2013 9:36:31 AM
TiGenix Completes EUR 12 Million Capital Increase With Strategic Investor Grifols 11/22/2013 9:28:33 AM
Novartis AG (NVS) Sells Diagnostics Business Unit To Grifols For $1.68 Billion 11/11/2013 6:57:41 AM
Grifols Announces Launch of the SPIRIT Registry at the NHF Annual Meeting 10/4/2013 7:08:15 AM
Grifols and Aradigm Corporation (ARDM) Complete the Closing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin® 8/28/2013 10:38:04 AM
Grifols Implements Its First Automated Inventory Management Carousel System for Investigational Pharmacies at Emory University 7/18/2013 9:28:30 AM
Grifols Study Demonstrates Higher Dose of PROLASTIN-C Increases Levels of Alpha1-PI to Within Normal Range in Patients With AAT Deficiency 5/22/2013 10:17:11 AM
Grifols Signs Deal to License Aradigm Corporation (ARDM)'s Pulmaquin for Up to $90.7 Million 5/21/2013 7:01:13 AM